We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Top Sells

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$180M
2
PXD
Pioneer Natural Resource Co.
PXD
+$121M
3
GE icon
GE Aerospace
GE
+$59.1M
4
UNH icon
UnitedHealth
UNH
+$46.6M
5
NVDA icon
NVIDIA
NVDA
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMO icon
3826
Imperial Oil
IMO
$61.1B
$682 ﹤0.01%
10
– –
ATER icon
3827
Aterian
ATER
$5.02M
$674 ﹤0.01%
240
– –
AMTD
3828
AMTD IDEA Group
AMTD
$71.5M
$664 ﹤0.01%
398
– –
GFL icon
3829
GFL Environmental
GFL
$15B
$661 ﹤0.01%
+17
New +$582
PASG icon
3830
Passage Bio
PASG
$14.1M
$621 ﹤0.01%
39
– –
SOHO
3831
DELISTED
Sotherly Hotels
SOHO
$612 ﹤0.01%
533
– –
DXF
3832
Eason Technology Ltd
DXF
$1.54M
$611 ﹤0.01%
26
+12
+86% +$380
SPRO icon
3833
Spero Therapeutics
SPRO
$73.5M
$595 ﹤0.01%
458
– –
CELU icon
3834
Celularity
CELU
$19.8M
$591 ﹤0.01%
189
– –
NUTX
3835
Nutex Health
NUTX
$1.05B
$580 ﹤0.01%
98
– –
TFII icon
3836
TFI International
TFII
$11.3B
$580 ﹤0.01%
4
-1
-20% -$141
VET icon
3837
Vermilion Energy
VET
$1.68B
$550 ﹤0.01%
50
– –
ANTX icon
3838
AN2 Therapeutics
ANTX
$219M
$537 ﹤0.01%
250
– –
STG
3839
Sunlands Technology
STG
$47.5M
$478 ﹤0.01%
61
– –
GRFX
3840
DELISTED
Graphex Group
GRFX
$471 ﹤0.01%
264
– –
NB
3841
NioCorp Developments
NB
$737M
$467 ﹤0.01%
270
-1,576
-85% -$3.67K
OMIC
3842
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$464 ﹤0.01%
55
– –
MTA
3843
Metalla Royalty & Streaming
MTA
$785M
$444 ﹤0.01%
160
– –
XOS icon
3844
Xos
XOS
$36.1M
$435 ﹤0.01%
63
-1
-2% -$8
TAL
3845
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$416 ﹤0.01%
39
– –
ABCL icon
3846
AbCellera Biologics
ABCL
$1.99B
$399 ﹤0.01%
135
– –
IPHA
3847
Innate Pharma
IPHA
$168M
$397 ﹤0.01%
205
– –
ASLN
3848
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$388 ﹤0.01%
162
– –
DCBO
3849
Docebo
DCBO
$520M
$386 ﹤0.01%
10
-15
-60% -$616
KEEL
3850
Keel Infrastructure Corp
KEEL
$2.31B
$372 ﹤0.01%
145
– –
152 153
154
155 156

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.